[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-496658-105":59,"doc-detail-496658-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","accfahaaseasnchfsahrsscaiscctscmrsts-2013-multimodality-appropriate-use-criteria-detection-and-risk-assessment-of-stable-ischemic-heart-disease","ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria - Detection and Risk Assessment of Stable Ischemic Heart Disease","","ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria address detection and risk assessment strategies for stable ischemic heart disease. The report is issued by an appropriate use criteria task force spanning major cardiovascular societies, with contributions from a multimodality writing group. It details the document’s purpose, preface, structured methods for indication development, rating process and scoring, and underlying assumptions. It also covers comparative rating, risk/benefit considerations, and contraindications.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/accfahaaseasnchfsahrsscaiscctscmrsts-2013-multimodality-appropriate-use-criteria-detection-and-risk-assessment-of-stable-ischemic-heart-disease/496658/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/accfahaaseasnchfsahrsscaiscctscmrsts-2013-multimodality-appropriate-use-criteria-detection-and-risk-assessment-of-stable-ischemic-heart-disease/496658.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-10-02",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical area does this document cover?","Question",{"text":112,"@type":113},"The document focuses on detection and risk assessment for stable ischemic heart disease using multimodality approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are indications and ratings developed?",{"text":117,"@type":113},"It describes indication development and a rating process with scoring as part of the methods section.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of assumptions and evaluation factors are included?",{"text":121,"@type":113},"The report outlines general and multimodality-specific assumptions, comparative rating, risk/benefit considerations, and contraindications.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},496658,1791096340,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Journal of the American College of Cardiology  \n􀀁 2014 by the American College of Cardiology Foundation Published by Elsevier Inc.  \nVol. 63, No. 4, 2014  \nISSN 0735-1097/$36.00 [http://dx.doi.org/10.1016/j.jacc.2013.11.009](http://dx.doi.org/10.1016/j.jacc.2013.11.009)  \n\n|  | \u003Cbr>APPROPRIATE USE CRITERIA |  |  |\n| --- | --- | --- | --- |\n| \u003Cbr>ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria\u003Cbr>for the Detection and Risk Assessment of\u003Cbr>Stable Ischemic Heart Disease |  | |  |\n\n\n|  | A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography,\u003Cbr>Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nMultimodality Writing Group for Stable Ischemic Heart Disease  \nMichael J. Wolk, MD, MACC, Chair  \nSteven R. Bailey, MD, FACC, FSCAI, FAHA  \nJohn U. Doherty, MD, FACC, FAHA  \nPamela S. Douglas, MD, MACC, FAHA, FASE  \nRobert C. Hendel, MD, FACC, FAHA, FASNC  \nChristopher M. Kramer, MD, FACC, FAHA  \nJames K. Min, MD, FACC Manesh R. Patel, MD, FACC Lisa Rosenbaum, MD  \nLeslee J. Shaw, PHD, FACC, FASNC, FAHA  \nRaymond F. Stainback, MD, FACC, FASE Joseph M. Allen, MA  \nTechnical Panel Ralph G. Brindis, MD, MPH, MACC, Moderator*  \nChristopher M. Kramer, MD, FACC, Writing Committee Liaison *  \nLeslee J. Shaw, PhD, FACC, FASNC, FAHA, Writing Committee Liaison *  \nManuel D. Cerqueira, MD, FACC, FASNCy Jersey Chen, MD, FAHAz  \nLarry S. Dean, MD, FACC, FAHA, FSCAIx  \nReza Fazel, MD, FACC*  \nW. Gregory Hundley, MD, FACCk Dipti Itchhaporia, MD, FACC* Paul Kligfield, MD, FACC, FAHA* Richard Lockwood, MD*  \nJoseph Edward Marine, MD, FACC{  \nRobert Benjamin McCully, MD, FACC, FASE\\#  \nJoseph V. Messer, MD, MACC* Patrick T. O’Gara, MD, FACC* Richard J. Shemin, MD, FACC**  \nL. Samuel Wann, MD, MACCyy John B. Wong, MD*  \nThis document was approved by the American College of Cardiology Foundation Board of Trustees in September 2013 .  \nThe American College of Cardiology Foundation requests that this document be cited as follows: Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Rosenbaum L, Shaw LJ, Stainback RF, Allen JM. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography,  \nSociety for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014;63:380–406.  \nThis document is copublished in the Journal of Cardiac Failure and Journal of Nuclear Cardiology.  \nCopies: This document is available on the World Wide Web site of the American College of Cardiology ([www.acc.org](www.acc.org)). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820, e-mail reprints@ [elsevier.com](elsevier.com).  \nPermissions: Modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Requests may also be completed online via the Elsevier site ([http://www.elsevier.com/authors/obtainingpermission-to-re-use-elsevier-material](http://www.elsevier.com/authors/obtainingpermission-to-re-use-elsevier-material)).  \nJACC Vol. 63, No. 4, 2014 Wolk et al. 381  \nFe","cbCaituiRdTA3CUh","https://ap.wps.com/l/cbCaituiRdTA3CUh","pdf",1146251,27,"English","# Preface\n# 1. Introduction\n# 2. Methods\n## Indication Development\n## Rating Process and Scoring\n# 3. Assumptions\n## General Assumptions/Considerations\n## Multimodality-Specific Assumptions/Considerations\n## Comparative Rating\n## Risk/Benefit\n## Contraindications","[{\"question\":\"What clinical area does this document cover?\",\"answer\":\"The document focuses on detection and risk assessment for stable ischemic heart disease using multimodality approaches.\"},{\"question\":\"How are indications and ratings developed?\",\"answer\":\"It describes indication development and a rating process with scoring as part of the methods section.\"},{\"question\":\"What types of assumptions and evaluation factors are included?\",\"answer\":\"The report outlines general and multimodality-specific assumptions, comparative rating, risk/benefit considerations, and contraindications.\"}]","ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria - Detection and Risk Assessment of Stable Ischemic Heart Disease | PDF",1790937661,68]